Andrea Di Pietro
@andreadipietro.bsky.social
Senior Research Fellow #cancerimmunology #melanoma #immunotherapies @Neeson_lab @petermaccc.bsky.social - He/Him 🏳️🌈
Today is the first day of fully supervising my new PhD student. Feeling nervous and excited at the same time — I hope I’ll be a good parent! 😆
February 23, 2025 at 8:32 PM
Today is the first day of fully supervising my new PhD student. Feeling nervous and excited at the same time — I hope I’ll be a good parent! 😆
Reposted by Andrea Di Pietro
#Melanoma that’s spread to the brain now appears to be curable!
Groundbreaking 7-year data from the ABC trial, out today in @TheLancetOncol, shows over 50% of patients achieved long-term disease control with combo immunotherapy.
More: www.petermac.org/about-us/new...
Groundbreaking 7-year data from the ABC trial, out today in @TheLancetOncol, shows over 50% of patients achieved long-term disease control with combo immunotherapy.
More: www.petermac.org/about-us/new...
February 18, 2025 at 3:09 AM
#Melanoma that’s spread to the brain now appears to be curable!
Groundbreaking 7-year data from the ABC trial, out today in @TheLancetOncol, shows over 50% of patients achieved long-term disease control with combo immunotherapy.
More: www.petermac.org/about-us/new...
Groundbreaking 7-year data from the ABC trial, out today in @TheLancetOncol, shows over 50% of patients achieved long-term disease control with combo immunotherapy.
More: www.petermac.org/about-us/new...
Reposted by Andrea Di Pietro
🧑🔬🏛️👩⚕️ Lots of our #CancerImmunology community now here 🦋, including @jimallisonphd.bsky.social 🏅! #AcademicSky #ImmunoSky #OncSky
#StarterPack 1 is already full 🙌, so starting a another one.
Let's continue growing!
- Pack 1️⃣: go.bsky.app/PRdmHCP
- Pack 2️⃣: go.bsky.app/93eqJbs
#StarterPack 1 is already full 🙌, so starting a another one.
Let's continue growing!
- Pack 1️⃣: go.bsky.app/PRdmHCP
- Pack 2️⃣: go.bsky.app/93eqJbs
November 25, 2024 at 6:18 PM
🧑🔬🏛️👩⚕️ Lots of our #CancerImmunology community now here 🦋, including @jimallisonphd.bsky.social 🏅! #AcademicSky #ImmunoSky #OncSky
#StarterPack 1 is already full 🙌, so starting a another one.
Let's continue growing!
- Pack 1️⃣: go.bsky.app/PRdmHCP
- Pack 2️⃣: go.bsky.app/93eqJbs
#StarterPack 1 is already full 🙌, so starting a another one.
Let's continue growing!
- Pack 1️⃣: go.bsky.app/PRdmHCP
- Pack 2️⃣: go.bsky.app/93eqJbs
How to train a … supervisor.
November 22, 2024 at 12:46 AM
How to train a … supervisor.
Waking up with an email containing the last validation data for a paper.
Rainbow Spongebob GIF
ALT: Rainbow Spongebob GIF
media.tenor.com
November 20, 2024 at 7:59 PM
Waking up with an email containing the last validation data for a paper.
Reposted by Andrea Di Pietro
Last month in #ScienceImmunology, Alex Chudnovskiy,
@victora.bsky.social, & al. used proximity-based labeling in combination with single-cell transcriptomics to characterize antigen-presenting dendritic cells in tumors and their draining lymph nodes.
@victora.bsky.social, & al. used proximity-based labeling in combination with single-cell transcriptomics to characterize antigen-presenting dendritic cells in tumors and their draining lymph nodes.
Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4+ T cell response
This study characterizes the dendritic cells that present antigen to tumor-specific CD4+ T cells in the tumor and tumor-draining lymph node.
www.science.org
November 19, 2024 at 4:59 PM
Last month in #ScienceImmunology, Alex Chudnovskiy,
@victora.bsky.social, & al. used proximity-based labeling in combination with single-cell transcriptomics to characterize antigen-presenting dendritic cells in tumors and their draining lymph nodes.
@victora.bsky.social, & al. used proximity-based labeling in combination with single-cell transcriptomics to characterize antigen-presenting dendritic cells in tumors and their draining lymph nodes.
Clean slate 🦋
November 18, 2024 at 12:22 AM
Clean slate 🦋